The innovation of this study lies in the integration of inflammatory biomarkers (IL-6, CRP, NSE), providing mechanistic insights into neuroprotection and systemic inflammatory modulation, strengthening the study’s translational relevance for traumatic brain injury management. The gene discussed is CRP; the disease is brain injury.